ArticleThe European journal of health economics : HEPAC : health economics in prevention and care2022
European union regulation of health technology assessment: what is required for it to succeed?
Article in The European journal of health economics : HEPAC : health economics in prevention and care, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed.
- Rigorous, transparent and inconclusive: what Europe's first joint clinical assessment reveals about a framework trying to serve everyone.Journal of comparative effectiveness research · 2026Review
- Physicians' Perspectives on Access to Innovative Oncology Therapies: A Cross-Sectional Survey in Bulgaria.Healthcare (Basel, Switzerland) · 2026Article
- Is Innovation Worth the Price? Cost-Effectiveness Analysis in Interventional Oncology.Cardiovascular and interventional radiology · 2026Review
- Implementing the EU HTA regulation and joint clinical assessment: a multi-stakeholder perspective from Italy.International journal of technology assessment in health care · 2026Article
- Health technology assessment (HTA) and performance management (PM): a scoping review on the intersecting realms.BMC health services research · 2025Article
- ARM's Perspective on the First Joint Clinical Assessments for ATMPs: Challenges and Opportunities on the Path Ahead.Journal of market access & health policy · 2025Article
- The Art of Bridge Building: A Look at the European-Level Cooperation in HTA (EU-HTA).Journal of market access & health policy · 2025Article
- From Vision to Reality: The EU's Pharmaceutical Reforms and the Path to Improved Access.PharmacoEconomics - open · 2025Article
- Mapping methods gaps between EU joint clinical assessments and local health technology assessment decision-making: an environmental scan of guidance in select EU markets and harmonization challenges.Journal of comparative effectiveness research · 2025Review
- The role and value of real-world evidence in health technology decision-making in France, Germany, Italy, Spain, and the UK: insights on external control arms.International journal of technology assessment in health care · 2025Review
- The EU Health Technology Assessment Regulation Halo Effect: Are Cross-Functional Teams Ready?Journal of market access & health policy · 2025Article
- Avoiding Error and Finding the Right Balance in European Health Technology Assessments: Insights Generated by the European Access Academy.Journal of market access & health policy · 2025Article
- "Towards harmonizing assessment and reimbursement of digital medical devices in the EU through mutual learning".NPJ digital medicine · 2024Review
- Opportunities and Challenges in Cross-Country Collaboration: Insights from the Beneluxa Initiative.Journal of market access & health policy · 2024Article
- Navigating the path towards successful implementation of the EU HTA Regulation: key takeaways from the 2023 Spring Convention of the European Access Academy.Health research policy and systems · 2024Article
- Article
- An Inclusive Civil Society Dialogue for Successful Implementation of the EU HTA Regulation: Call to Action to Ensure Appropriate Involvement of Stakeholders and Collaborators.Journal of market access & health policy · 2024Article
- Surrogacy and the Valuation of ATMPs: Taking Our Place in the Evidence Generation/Assessment Continuum.PharmacoEconomics · 2024Article
- Implementing the EU HTA regulation: Insights from semi-structured interviews on patient expectations, Belgian and European institutional perspectives, and industry outlooks.Frontiers in pharmacology · 2024Article
- Which value aspects are relevant for the evaluation of medical devices? Exploring stakeholders' views through a Web-Delphi process.BMC health services research · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
35348920What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.